Clinical Trial Update: An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A

View source ↗

Summary

This Bayer-sponsored observational study aims to evaluate how well damoctocog alfa pegol works in previously treated children with Hemophilia A, and it is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Damoctocog alfa pegol (damoctocog alfa pegol)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: NOT_YET_RECRUITING